- Home
- ULS vs RVTY Comparison
ULS vs RVTY Comparison
Compare ULS & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ULS | RVTY |
|---|---|---|
| Founded | 1894 | 1937 |
| Country | | |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9B | 11.8B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ULS | RVTY |
|---|---|---|
| Price | $70.52 | $95.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 15 |
| Target Price | $80.38 | ★ $113.00 |
| AVG Volume (30 Days) | 978.4K | ★ 1.6M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 0.74% | 0.29% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.21 | $6.34 |
| Revenue Next Year | $5.56 | $5.10 |
| P/E Ratio | ★ $42.28 | $45.95 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $49.34 | $81.36 |
| 52 Week High | $91.95 | $120.39 |
Technical Indicators
Market Signals| Indicator | ULS | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 41.84 | 35.98 |
| Support Level | $68.38 | $93.70 |
| Resistance Level | $73.55 | $106.55 |
| Average True Range (ATR) | 2.40 | 4.25 |
| MACD | 0.17 | -1.69 |
| Stochastic Oscillator | 41.41 | 7.12 |
Price Performance
Historical ComparisonAbout ULS UL Solutions Inc.
UL Solutions is a global leader specializing in a broad range of product testing, inspection, and certification services. UL Solutions is the for-profit branch out of three organizations under the UL Enterprise. TIC operations make up nearly all of UL Solutions' total revenue and are composed of two segments: industrial and consumer. UL Solutions' remaining business includes software and advisory, which complements its core TIC offerings. The firm operates globally.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.